Skip to content

Safety and Efficacy Evaluation of Ultherapy™ System in Aging Hand

Safety and Efficacy Evaluation of Ultherapy™ System in Aging Hand

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02364440
Enrollment
7
Registered
2015-02-18
Start date
2015-02-28
Completion date
2015-05-31
Last updated
2015-05-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wrinkles

Keywords

skin laxity, Ultherapy™ System, rhytids

Brief summary

Enrolled subjects will receive Ultherapy™ System treatment on the back of their both hands. Follow-up visits will occur at 90 days post-treatment. Study photos will be obtained pre-treatment and at 90 days post-treatment

Detailed description

Before Treatment: The subject's eligibility (inclusion/exclusion criteria) will be assessed, and the 5-point Hand Grading Scale wil be evaluated by the Investigator in charge of assessment. Treatment: The Investigator will apply to the eligible subject the Study Device Ultherapy™ System with 20 lines of 1.5 and 3.0 probe respectively to the back of the left and right hand . Post-Treatment: All subjects will visit the Institution at12 weeks from the day of procedure, and will take photos of the back of the hands. Efficacy evaluation will performed by the Photographic Evaluator.

Interventions

Subjects will receive 20 lines Ultherapy™ System Treatment over their right and left hand with 1.5 and 3.0 probe respectively

Sponsors

Ministry of Health & Welfare, Korea
CollaboratorOTHER_GOV
Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male or female, aged 30 to 65 years. * Score of 1 to 3 on The 5-point Hand Grading Scale * Subjects who understand the study contents and signed the informed consent

Exclusion criteria

* Presence of an active systemic infectious disease * Significant scarring in the hand to be treated * Previous episode of surgery in the hand to be treated * Subjects who have aesthetic addiction, drug abuse, alcohol abuse

Design outcomes

Primary

MeasureTime frameDescription
Investigator's evaluation of 5-point Hand grading scale12 weeks post-treatment2 assessors will be evaluate 5-point Hand grading scale from baseline and 12weeks post treatment

Secondary

MeasureTime frameDescription
Subject Assessment of Improvement at 12 weeks post-treatment12 weeks post-treatmentSubjects complete a Patient Assessment Global Aesthetic Improvement Scale at 12 weeks post-treatment
Investigator Assessment of Improvement at 12 weeks post-treatment12 weeks post-treatmentInvestigator complete Global Aesthetic Improvement Scale at 12 weeks post-treatment by comparing subject's photographs
Subjects' Assessment of Pain during treatmentSubjects were assessed for the duration of study treatmentPain score record using a Numeric Rating Scale (NRS,0-10) , with 0 representing no pain and 10 representing the worst pain possible.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026